1. Home
  2. SER

as 05-24-2024 3:32pm EST

$
-
-
.
-
-
+$
-
.
-
-
+
-
.
-
-
%

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

Serina Therapeutics Inc is a clinical-stage biotechnology company developing a pipeline of wholly-owned drug product candidates to treat neurological diseases and pain. Serina's POZ Platform delivery technology is engineered to provide control in drug loading and more precision in the rate of release of attached drugs, enabling the potential of certain challenging small molecules, while addressing the limitations of polyethylene glycol (PEG) and other biocompatible polymers.

Founded: 2017 Country:
United States
United States
Employees: N/A City: HUNTSVILLE
Market Cap: 79.9M IPO Year: 2018
Target Price: N/A AVG Volume (30 days): 9.2K
Analyst Decision: N/A Number of Analysts: N/A
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: 1.25 EPS Growth: -11.83
52 Week Low/High: $7.86 - $35.71 Next Earning Date: 05-14-2024
Revenue: $3,148,500 Revenue Growth: 410.71%
Revenue Growth (this year): N/A Revenue Growth (next year): N/A

Share on Social Networks: